materials-logo

Journal Browser

Journal Browser

Nanotechnology-Based Materials in Developing Disease-Modifying Therapies and Early Detection

A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Advanced Nanomaterials and Nanotechnology".

Deadline for manuscript submissions: 20 December 2025 | Viewed by 57

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chemistry and Biochemistry, The University of Texas at El Paso, El Paso, TX, USA
Interests: polymers; material synthesis and characterization; protein misfolding; neurodegenerative disorders; oxidative stress; tissue engineering and toxicology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Environmental & Occupational Health Sciences, School of Public Health in El Paso, University of Texas Health Science Center at Houston, 5130 Gateway Boulevard East, El Paso, TX 79905, USA
Interests: border health; community health practice; environmental and occupational health; epidemiology; global health; health equity

Special Issue Information

Dear Colleagues,

Over the years, nanotechnology-based materials have transformed disease-modifying therapies and advanced diagnostic systems for various medical conditions. Their unique physicochemical properties, such as their high surface-to-volume ratio, tunable size, and surface chemistry, facilitate the development of targeted drug delivery systems (DDSs) with enhanced therapeutic efficacy and reduced systemic toxicity. Furthermore, nanomaterials can be engineered to respond to specific stimuli, such as pH changes or enzymatic activity, enabling controlled, localized, and sustained drug release. Additionally, nanoscale biosensors and imaging agents are revolutionizing early detection, offering increased sensitivity and specificity in identifying biomarkers associated with diseases such as cancer and degenerative disorders. These strategies can be used to intervene in disease progression with efficiency. Despite the promise of these innovations, challenges related to biocompatibility, regulatory frameworks, and large-scale production still exist. Addressing these concerns is paramount and requires interdisciplinary collaborations to ensure the safety, scalability, and cost-effectiveness of these advanced therapies. These breakthroughs hold the potential to improve disease management via improved detection and personalized treatments.

Dr. Jyoti Ahlawat
Dr. Eva M Deemer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanotechnology
  • disease-modifying therapies
  • early detection
  • targeted drug delivery
  • biosensors
  • theranostic
  • biomarker
  • biocompatibility

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop